Does RAMUCIRUMAB Cause Interstitial lung disease? 269 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 269 reports of Interstitial lung disease have been filed in association with RAMUCIRUMAB (CYRAMZA). This represents 5.0% of all adverse event reports for RAMUCIRUMAB.
269
Reports of Interstitial lung disease with RAMUCIRUMAB
5.0%
of all RAMUCIRUMAB reports
55
Deaths
131
Hospitalizations
How Dangerous Is Interstitial lung disease From RAMUCIRUMAB?
Of the 269 reports, 55 (20.4%) resulted in death, 131 (48.7%) required hospitalization, and 19 (7.1%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
Yes, Interstitial lung disease is listed as a known adverse reaction in the official FDA drug label for RAMUCIRUMAB.
What Other Side Effects Does RAMUCIRUMAB Cause?
Malignant neoplasm progression (743)
Death (492)
Febrile neutropenia (229)
Neutropenia (229)
Decreased appetite (187)
Diarrhoea (186)
Hypertension (175)
Pyrexia (161)
Nausea (160)
Fatigue (159)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which RAMUCIRUMAB Alternatives Have Lower Interstitial lung disease Risk?
RAMUCIRUMAB vs RANEXA
RAMUCIRUMAB vs RANIBIZUMAB
RAMUCIRUMAB vs RANIMUSTINE
RAMUCIRUMAB vs RANITIDINE
RAMUCIRUMAB vs RANITIDINE\RANITIDINE